Yunjun Xiao Selected Research

S-Adenosylhomocysteine

2/2022	Betaine Supplementation Attenuates S-Adenosylhomocysteine Hydrolase-Deficiency-Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice.
1/2022	Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification.
1/2019	Inhibition of S-Adenosylhomocysteine Hydrolase Induces Endothelial Dysfunction via Epigenetic Regulation of p66shc-Mediated Oxidative Stress Pathway.
10/2015	Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
1/2015	Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
11/2013	Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunjun Xiao Research Topics

Disease

11	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 08/2011
5	Atherosclerosis 02/2022 - 07/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 08/2011
3	Inflammation (Inflammations) 02/2022 - 04/2012
2	Obesity 02/2019 - 04/2011
2	Hyperhomocysteinemia 01/2015 - 11/2013
1	Hypermethioninemia 02/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Poisoning 05/2020
1	Lung Neoplasms (Lung Cancer) 05/2020
1	Dyslipidemias (Dyslipidemia) 02/2019
1	Infections 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Persistent Infection 01/2019
1	Heart Failure 02/2014
1	Stroke (Strokes) 11/2013
1	Myocardial Infarction 11/2013
1	Goiter 09/2013
1	Atherosclerotic Plaque (Atheroma) 07/2012
1	Non-alcoholic Fatty Liver Disease 04/2012

Drug/Important Bio-Agent (IBA)

7	HomocysteineIBA 10/2021 - 08/2011
6	S-AdenosylhomocysteineIBA 02/2022 - 11/2013
2	ApolipoproteinsIBA 02/2022 - 07/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2013
2	InflammasomesIBA 01/2021 - 04/2012
2	Apolipoproteins E (ApoE)IBA 01/2015 - 07/2012
2	LipidsIBA 04/2012 - 08/2011
1	Betaine (C.B.B.)FDA Link 02/2022
1	AdenosylhomocysteinaseIBA 01/2022
1	S-Adenosylmethionine (Ademetionine)IBA 10/2021
1	periodate-oxidized adenosineIBA 01/2021
1	NLR ProteinsIBA 01/2021
1	pyreneIBA 05/2020
1	benzo(a)pyrene- 7,8- dihydrodiol- 9,10- epoxide- DNAIBA 05/2020
1	Benzo(a)pyreneIBA 05/2020
1	CarbonIBA 05/2020
1	S 10 (S-10)IBA 05/2020
1	IronIBA 02/2019
1	Ferritins (Ferritin)IBA 02/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2018
1	CurcuminIBA 01/2018
1	Heme Oxygenase-1IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Histones (Histone)IBA 01/2015
1	CholesterolIBA 02/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2014
1	Antihypertensive Agents (Antihypertensives)IBA 02/2014
1	HDL CholesterolIBA 02/2014
1	Plant ProteinsIBA 11/2013
1	IodineIBA 09/2013
1	Phosphates (Orthophosphate)IBA 01/2013
1	Vitamin D FDA LinkGeneric 01/2013
1	Fibroblast Growth Factor-23IBA 01/2013
1	Malondialdehyde (Propanedial)IBA 07/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2012
1	Docosahexaenoic AcidsIBA 04/2012
1	PalmitatesIBA 04/2012
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2012
1	Cysteine (L-Cysteine)FDA Link 08/2011
1	Anthocyanins (Anthocyanin)IBA 04/2011
1	Triglycerides (Triacylglycerol)IBA 04/2011
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 04/2011